The invention relates to a device for an intermittent or continuous administration of a therapeutical substance, such as insulin, comprising an injection part and a fluid delivery part. The fluid delivery part normally comprises a reservoir, transferal means e.g. in form of a pump and a house, and the injection part normally comprises a base plate, a cannula part comprising a cannula extending past the proximal side of the base plate and means for fixation of the base plate to the skin of the user.
Both EP-A1-1.527.792 and EP-A1-1.495.775 describe a medical device comprising a transdermal access unit and a reservoir. The transdermal access unit comprises transdermal access means for transporting a fluid through a skin portion of a subject, and a mounting surface adapted for application to the skin of the subject. The reservoir unit comprises a reservoir adapted to contain a fluid drug and an outlet allowing the transdermal access means to be arranged in fluid communication with an interior of the reservoir. Also the device comprise means for expelling e.g. a pump which means during use expels a fluid drug out of the reservoir and through the skin of the subject via the transdermal access means. The transdermal access unit and the reservoir unit further comprise releasable mating coupling means allowing the reservoir unit to be secured to the transdermal access unit during use. The object of the invention is to provide a skin mountable drug delivery device or system which allows such a device or system to be used in a convenient and cost-effective manner.
According to this document the insertion needle (113, 212 or 412) of the described embodiments is pivotably arranged inside the needle housing and can be moved between an extended and an extracted position. When the injection needle is inserted it penetrates a membrane in order to penetrate the skin of the subject. After the needle has been inserted there is no flexible effect in the system.
US 2004/0204673 A1 describes a lightweight and low cost fluid delivery device capable of adjustable and programmable fluid delivering; the device includes a housing that surrounds a reservoir chamber. A dispenser is in fluid communication with the reservoir chamber for dispensing the fluid from the reservoir in finite amounts. The dispenser is controlled by an electronic microcontroller of the fluid delivery device. The fluid delivery device further includes a communication element that receives information from a remote control device not mechanically attached to the fluid delivery device of the present invention. Also included is an exit port assembly in fluid communication with the dispenser from which the liquid medication exits the fluid delivery device and enters the body of a mammalian patient transcutaneously.
The housings 702, 802 can each be made from flexible material, or can be provided with flexible hinged sections that allow the fluid delivery device 10 to flex during patient movement to prevent detachment and aid in patient comfort but there are no directions as to how such a hinged section should be constructed.
The object of the invention is to provide a device for delivering fluid including a pump, a reservoir and an injection part which device assures less discomfort to the wearer during use. The devices according to the present invention are constructed with means to reduce the transferal of actions from the relatively heavy delivering part to the injection part when the delivering part is affected by touches or movements.
According to claim 1 the invention comprises a device for delivering fluid comprising an injection part and a fluid delivery part where the fluid delivery part comprises a reservoir, transferal means e.g. in form of a pump and a house, and the injection part comprises a base plate, a cannula part comprising a body providing a through-going opening leading liquid to a cannula which cannula extends past the proximal side of the base plate and means for fixation of the base plate to the skin of the user wherein a flexible part is arranged in an area between the subcutaneously positioned section of the cannula and the fluid delivery part.
That a part is flexible means that it is resilient, able to be deformed without breaking, non-rigid, it is not purely a rigid material moving from one position to another, it has a certain degree of elasticity such that when one end of the flexible part is subjected to external influencing factors e.g. pushing and pulling effects these external effects are not transferred directly to the cannula when the cannula is inserted but the effects are at least partly absorbed. The flexibility need not be a result of the material characteristic but can be a result of the physical structure of the material e.g. the material is corrugated or the like. As the delivery part is susceptible for external influencing factors such as pulling and pushing effects when the user is moving around, it is desirable that these effects are not transferred to the cannula which is positioned through the user's skin. The flexible part will at least partly absorb these effects and assure that the cannula is not influenced i.e. pulled out or moved around thereby causing discomfort or pain for the user.
According to one embodiment the flexible part is integrated in the base plate according to this embodiment the base plate can be constructed either partially or completely by a flexible material.
According to a second embodiment the flexible part is integrated in the body of the cannula part providing a through-going opening leading liquid to a cannula according to this embodiment the body of the cannula part can be constructed either partially or completely by a flexible material.
According to a third embodiment the flexible part is integrated in the fluid delivery part.
According to a fourth embodiment the flexible part is a separate unit placed between the fluid delivery part and the injection part. According to this embodiment the separate unit can be constructed either partially or completely by a flexible material.
That the cannula part and/or a base plate and/or a separate unit is/are constructed partially by a flexible material can mean that a fraction of the full area of the part/plate/unit is e.g. made by a different material or made with a structure such as holes, which structure increases the elasticity of the material in one or more dimensions. If the part/plate/unit is constructed completely by a flexible material the choice of material together with the dimensions of the material e.g. the thickness of the part/plate/unit and/or the form of the periphery will define the flexibility.
A suitable flexible material for each of the mentioned units would be an elastomer.
When the flexible part is a separate unit it forms an interface between the injection part and the delivery part thereby providing a flexible transition which provides absorption of the transferable effects originating from the weight and volume of the fluid delivery device.
According to one embodiment the fluid delivery part and the injection part can be separated and rejoined.
According to one embodiment the base plate is provided with fastening means for connecting and disconnecting of the delivery device extending from the distal side of the base plate.
According to one embodiment the house of the fluid delivery part also provides a house for the injection part.
When the house is provided by the fluid delivery part it is possible for the user to visually check the complete fluid path as the house of the fluid delivery part can provide a fully removable protective cover. Also it is possible to create the flexible base part without a house or protective cover which could make the base part less flexible.
According to one embodiment the flexible part is constructed of an area with reduced material dimensions. “Reduced material dimensions” could be both reduction of thickness i.e. “height” of the material and reduction of transverse section i.e. “width” of the material.
According to a second embodiment the flexible part is constructed of an area made by a softer and more flexible/elastic material.
According to a third embodiment the flexible part is constructed of an area made of a material which by its form has an ability for extension and compression such as a material being pleated or folded or corrugated.
According to one embodiment the cannula and the delivery part are not interconnected by non-flexible areas.
According to one embodiment a fluid tight connection leading fluid from the reservoir to the cannula is formed when the delivery part and the injection part are joined together.
According to one embodiment the access of micro organisms to the reservoir of the fluid delivery part during periods when the fluid delivery part and the injection part are separated is prevented as the opening to the reservoir is blocked when the two parts are separated.
According to one embodiment the reservoir has two positions, a first position and a second position, in the first position the outlet from the reservoir is blocked with a first barrier which is not permeable for microorganisms and the inlet of the through-going opening in the cannula part is blocked with a second barrier which is not permeable for microorganisms, in the second position an open fluid connection is formed between the reservoir and the through-going opening in the cannula part by passing the first and the second barrier. According to this embodiment one or both of the barriers comprise a material which can be penetrated by a needle-like object where the opening close on retraction of the needle-like object. The needle-like object can be blunt or sharp-pointed. One or both of the barriers can comprise a hard surface which is moved forming an opening in the area positioned between the outlet of the outlet pipe and the inlet of the through-going fluid path.
According to one embodiment the means for fixation of the base plate to the skin of the user comprises a mounting pad adhered to the proximal side of the base plate and/or to the proximal side of the cannula part.
According to one embodiment the base plate has the form of a lattice with a peripheral coherent part and one or more bars interconnecting the peripheral part. The base plate can have a round or oval peripheral part and the bars have one end attached to the peripheral area and a second end attached to a central area. The base plate can have three or more bars.
According to one embodiment the base plate is not provided with a cannula holding part before use e.g. the base plate is provided with an opening through which a cannula holding part can be inserted.
According to one embodiment the cannula at one end is provided with a body which body comprises solid walls and a protective seal protecting the fluid entrance to the cannula.
According to one embodiment injection part comprising the base plate is provided with a first part of a cannula part acting as positioning controller for a second part which second part comprises a cannula and is to be inserted with an injection needle.
The cannula can be inserted with an inserter device provided with means corresponding to the surface of the base plate, and when said means of the inserter device are combined with the corresponding surface of the base plate, the inserter device is positioned in such way that the cannula, e.g. a cannula including a body, is inserted predictably and correct in relation to the base part. E.g. a first part of the cannula part is provided with means for locking a second part in a desired position.
According to one embodiment the base plate is unreleasably connected to a mounting pad.
A “reservoir” is the part of a device where the liquid is held, the liquid being any kind of medication which has to be delivered to the patient in a certain amount at certain time intervals. The “delivery part” is the part of the device which holds a liquid storage and assures transport of the liquids to the injection part by pumping and e.g. controlling the amount of added liquid. The “injection part” defines a kind of port which is fastened to the users skin and provided with means e.g. a cannula for transferring the liquid to the user and the injection part do not comprise any heavy or voluminous parts. The injection part can comprise two or more separable parts, where one or more parts are unreleasably connected to the base part and one or more parts can be fastened to the base part before or after fastening of the base part to the skin of the patient.
When the flexible areas are placed between the relatively heavy delivery device and the injection device, the transferal of actions from the delivery device to the injection device is prevented or at least significantly reduced, and the injection site of the subcutaneously placed cannula will be protected from the main part of any interaction resulting from pushing or touching the delivery part. Often the delivery part is separated physically from the injection part by a relatively long tube which prevents the transferal of actions but when the delivery part is positioned together with the injection device, the user will feel less discomfort when wearing a device according to the invention.
By using a connector it is possible to avoid the direct contact between the delivery part and the injection part and at the same time fasten both parts as one unit to the skin of the patient.
The cannula can protrude from the proximal side of the body of the injection part or from the side of the body. If the cannula protrudes from the side of the body as it does in the embodiments shown in
According to the invention the connector needle can be one end of a single needle which at the other end functions as the cannula. When the connector needle and the cannula is formed as one needle, the needle is normally made of metal or hard polymer but it can also be made of e.g. a polymer which is hardened in the connector end and unhardened and soft in the cannula end. Also the single needle can be composed of two different materials, a hard material for the connector end and a relatively soft material for the cannula end. Also the connector needle and the cannula can be separated into at least two needles. The injector part can then be provided with a commonly known soft cannula which cannula can be inserted by the help of an insertion needle attached to a separate inserter, and the connector needle can be made of a hard material and fastened to either the injector part or the delivery part.
The flexible areas are constructed of an area with reduced material dimensions, e.g. openings or cuts can be provided in a material or the thickness of a material can be reduced, or of an area made by a softer and more flexible material or it is constructed of an area made of a material which by its form or structure has ability for extension and compression such as a material being pleated or folded.
Access of micro organisms to the reservoir during a non-connected state, i.e. when the reservoir and the injection part are separated, is prevented as the opening to the reservoir is blocked when the two parts separate. When e.g. a connector needle is attached to the delivery device the opening in the septum of the connector will close upon removal of the connector needle.
In another embodiment the reservoir of the delivery part has two positions, a first position and a second position, in the first position the outlet from the reservoir is blocked with a first barrier which is not permeable for micro organisms and the inlet of the through going opening in the injection part is blocked with a second barrier which is not permeable for micro organisms, in the second position an open fluid connection is formed between the reservoir and the through going opening in the injection part by passing the first and the second barrier. The word “passing” comprise all possible ways to make a flow pass through or around a barrier, in most of the described embodiments of this invention the barrier is passed by penetrating the barrier with a needle but there is also an example (
If the barriers comprise a material which can be penetrated by a needlelike object, where the opening close on retraction of the needle like object, the needlelike object can be either blunt or sharp-pointed meaning that the needlelike object either pushes its way through the barrier or cuts its way through the barrier.
In another embodiment at least one of the barriers comprise a hard surface, i.e. a surface which cannot be penetrated by at least a blunt needle, which is moved forming an opening in the area positioned between the outlet of the outlet pipe and the inlet of the through going fluid path.
The device is often fastened to the patients skin by applying a mounting pad to the proximal side of the base part or to the proximal side of the infusion part, the adhering of the mounting pad to the base part or infusion part can include glue, Velcro, molding etc.
In one embodiment the base part has the form of a lattice with. The peripheral part can either be formed with opening or be formed as a coherent part constituting the circumference of the base part. That the base part has the form of a lattice means that is formed of one or more bars interconnecting with each other and with the peripheral part if present. A base part of this form can easily be provided with a desired flexibility and can take any desired form which might be needed in order to fit the injection part and the delivery part to the mounted device.
In one embodiment the injection part is constructed of at least two separable parts where the first part is unreleasably connected to the base part and the second part comprising the cannula is placed in the first part before or after mounting of the base part on the skin of the patient. The partitioning of the injection part has the advantage that it makes applying of the device much more flexible. The second part can comprise a relatively small body where from a cannula extend from the proximal end and a septum protects the distal end. The second part can e.g. be sold together with a base part already being mounted in an inserter.
If the injection part is constructed of more than one separable part the first part can be provided with means for locking the second part in a desired position. Also the second part can be provided with means for locking the second part to the first part in a desired position or the first and the second part can each be provided with corresponding locking means.
Embodiments of the invention will now be described with reference to the figures in which:
a and 39b both shows the delivery part of the tenth embodiment seen from below, in
a-b shows different embodiments of the house of the delivery part which also function as house for the injection part.
The base plate 10 will normally at the proximal side be fastened to the patient by an adhesive part or layer but any kind of mounting which will make the base plate 10 stick to the patient without allowing the device to move can be used. The adhesive part or layer can be fastened to the base plate 10 by glue, Velcro, molding or the like.
In a preferred embodiment the delivery part is fastened to the distal side of the base plate 10 by one or more magnets which are embedded in the base plate 10. The detachable delivery part has corresponding magnets which keeps the delivery part in position during use. By means of the magnets of the base plate 10 and/or the delivery part 3, 4 it will be possible to detect conditions of the system such as whether the delivery part is secured properly, if the flow through the device is acceptable, how long has the delivery part been fastened to the base plate, size of the volume which has passed the device, etc.
In the first embodiment described in
The cannula 9 can together with the rest of the injection part be inserted subcutaneously either by the help of an inserter or manually.
The house 3 of the delivery part 3, 4 is made of a relatively hard material such as PP or ABS (Poly (Acrylo nitrile, Butadiene, Styrene)) which makes it possible for the house to resist impacts of the surroundings.
In the second embodiment the injection part 1 is connected to the delivery part 3, 4 by a flexible tube 5 which in this embodiment is formed as a bellows and preferably is made of silicone, PUR, PP/PE or the like. The flexible portions 12 of the base part 10 is formed as relatively thin V-shaped connections made by removing material from the plane of the base part 10. This embodiment is provided with sliding rails 11 acting as objects for fastening of the delivery part 3, 4 to the base part 10. In this embodiment the connector needle 6 is fastened to the delivery part 3, 4. The connector needle 6 penetrates a septum 7 when the delivery part is joined to the connector 2 and thereby creates a flow path from the reservoir 4 to the cannula 9.
In
The delivery part 3, 4 is combined with a connector 2; the connector 2 has a through-going connector needle 6 and is influenced by a spring 15. When the user pushes the delivery part 3, 4 towards the injection part, the spring 15 is compressed and the through-going connector needle 6 is forced through a septum 8 protecting the content of the reservoir from being infected with micro organisms. At the same time or just before or afterwards the connector needle 6 will also be forced through a septum 7 protecting the access to the cannula 9 thereby forming a fluid connection between the not shown reservoir and the cannula 9. By choosing convenient materials for the spring 15, the septum 8 and other materials being in contact with the connector 2, it should be assured that there exists a flexible connection between the connector 2 and the delivery part 3, 4. Preferably the connector 2 is fastened to the spring 15 while the movement from one position to another is guided by the walls of the central extension of the delivery part 3, 4, and the septum 8 is made of a material which is adequately soft to assure that the connector 2 is flexibly connected to the delivery part 3, 4 when the device is in a connected state. In this embodiment the connector 2 does not have to be fastened to neither the delivery part 3, 4 nor the injector part 1, the connector 2 can be a separate unit which functions as an independent interface or it can be integrated with either the delivery part 3, 4 or the injection part.
In
The embodiment shown in
When introducing the flexible areas as described in
All the embodiments containing is fastened to the patients skin and this is normally done by applying a mounting pad adhered to the proximal side of the base part 10 or to the proximal side of the infusion part if the embodiment is not provided with a base part 10. The adhering of the mounting pad to the base part 10 or infusion part 1 can include glue, Velcro, molding etc.
In
In
In a first position the delivery part comprising the reservoir 4 and the pump is retracted from the injection part, the first spring 15 is extended and the outlet from the outlet pipe 22 is blocked by the wall of the central part of the injection part i.e. the cannula part 1. The lower packing 18 is in a high position where it blocks the inlet of the fluid path 23 and the second spring 19 is extended.
In a second position the delivery part 3, 4 is pushed towards the injection part and both the first spring 15 and the second spring 19 are compressed. The lower packing 18, which in the first position functions as a barrier for bacteria, is pushed down by the lower edge of the delivery part 3, 4 and thereby opens the inlet of the fluid path 23. When the tongues 25 of the injection part touch the upper side of the grooves 24 of the delivery part 3, 4 the downward movement of the delivery part stop and in this position the opening of the outlet pipe 22 corresponds to the inlet of the fluid path 23.
The membranes 26 and 27 can be made of silicone or polyurethane (PUR) or other soft polymers which can be penetrated by a needle but not by micro organisms.
The connector needle 6 is made of a relatively hard material such as metal or a hard polymer, “a relatively hard material” means that the material should at least have the strength, i.e. be hard enough, to penetrate the membranes 26 and 27.
In the embodiment of
It is also possible to separate the connector needle 6 and the cannula 9 and produce the device according to the invention with two needles. The injector part 1 can then be provided with a commonly known soft cannula which cannula can be inserted by the help of an insertion needle attached to a separate inserter, and the connector needle 6 is made of a hard material and fastened to either the injector part 1 or the delivery part 3, 4.
In this embodiment the single needle is bend, i.e. the connector needle 6 points in a direction parallel to the patients skin while the cannula 9 points in a direction perpendicular to the patients skin. According to the present invention the connector needle 6 can point in any direction parallel or away from the patient and the cannula 9 can point in any direction according to which the cannula can be inserted into the patient's skin.
The device according to the invention can be used in connection with all kinds of medicaments and all kind of conditions where patients can benefit from a continuous intake of a drug product; preferably it is the intention to provide patients suffering from diabetes with a secure and easy-to-handle device which can provide the patient with continuously regulated doses of insulin.
In one embodiment the reservoir is divided into several separate chambers where each chamber can be provided with different drug products or e.g. an active drug substance in one chamber and a solvent in another chamber, the different chambers can contain drugs of different concentrations or drugs with different active substances.
In this embodiment the flexible part is integrated in the base plate 10 by providing a flexible portion 12 constructed from the base plate 10 and formed like four spokes in a wheel. It is possible to vary the elasticity of the flexible portions 12 by varying the width of the portions 12, the thickness of the base plate material 10 or the number of portions 12 (spokes).
The cannula part is a two-part unit comprising a first part 1a which is fastened unreleasably to the base plate 10 and a second part 1b comprising a body providing a through-going opening leading liquid to the cannula 9 which cannula 9 extends at the proximal side of the base plate 10 after insertion. The cannula part 1a, 1b partly forms the fluid connection between the patient and the reservoir 4.
It is possible to position this embodiment on the skin of the patient applying at least two different methods. According to one method the base plate 10 comprising the first part 1a is first positioned on the skin of the patient and thereafter the cannula-holding second part 1b of the cannula part 1 is injected e.g. with an especially adapted inserter, this method makes it possible for the user to exercise more care when positioning the base plate 10 which is normally equipped with an adhesive pad. According to a second method the base plate 10 comprising both the first part 1a and the cannula-holding second part 1b is injected all together with an inserter adapted to hold the entire device, this method comprises one less mounting step compared to the earlier described method.
In this embodiment the first part 1a is provided with inward projecting parts 1c and the second part 1b is provided with outward projecting, pivotably fastened hooks 1d. When the second part 1b is positioned in the first part 1a, the outward projecting hooks 1d are first pushed outward by the inward projecting parts 1c and after having passed the projecting parts 1c, the projecting hooks 1d return to their original position and locks the first part 1a inside the second part 1a.
The base plate 10 is provided with three upright positioned objects 11 for fastening of the delivery part 3, 4 to the base plate 10; the numbers of objects 11 are optional and the objects 11 can be either molded together with the base plate 10 or fastened to the base plate 10 after the base plate 10 has been formed e.g. by gluing or welding. The objects 11 are provided with sliding grooves 11a which sliding grooves 11a define the direction in which to move the delivery part 3, 4 when securing the delivery part 3, 4 to the base plate 10. The sliding grooves 11a correspond to protruding parts 1b on the delivery part 3, 4. In this embodiment the sliding grooves 11a are not parallel with the surface of the base plate 10 but differs in an angle B: 0°<B<45° where one side of the angle B is the distal surface of the base plate 10 and the other side of the angle B is the distal edge of the sliding grooves 11a. The angle B—together with the round shape of the delivery part 3, 4 and the central position of the connector 2—makes it possible to screw the delivery part 3, 4 on to the base plate 10.
The connector 2 is constructed of a molded body fastened unreleasably to the base plate 10 and provided with an interior compartment to which access is protected by a septum 7. The septum 7 is penetrated by the connector needle 6 when the delivery part 3, 4 is fastened to the base plate 10. From the lower part of the interior compartment and opening 5a allows fluid to enter into the flexible tube 5 and pass onto the patient through the cannula 9. The flexible tube 5 is connected to the first part 1a of the injection part and when the second part 1b of the cannula part is positioned in the first part 1a a fluid path is created from the flexible tube 5 to the cannula 9.
The reservoir 4 of the shown embodiment will normally hold between 0.5-3 ml of fluid for transferal to the patient.
In this embodiment the flexible portion 12 is also constructed from the base plate 10 and formed like four spokes in a wheel.
The cannula part 1 is one unit comprising a molded body with an interior compartment. The interior compartment can be accessed through the protective seal 7 by the connector needle 6 when the delivery part including the reservoir 4 is placed in correct position. From the interior compartment fluid can be channeled out through the cannula 9.
The base plate 10 is like the embodiment of
In the embodiment of
In this embodiment the flexible portion 12 is also constructed from the base plate 10 and formed like four spokes in a wheel.
The cannula part is a two-part unit comprising a first part 1a which is fastened unreleasably to the base plate 10 and a second part 1b comprising the cannula 9. According to this embodiment the base plate 10 is positioned on the skin of the patient first and then the cannula-holding part 1b of the cannula part is injected in the allocated position. Like the embodiment shown in
The flexible portion 12 of this embodiment is also constructed from the base plate 10 but here the flexible portion 12 is formed like a lattice. According to this embodiment it is also possible to vary the flexibility of the flexible portions 12 by varying the width of the portions 12, the thickness of the base plate material 10 or the number of portions i.e. bars 12.
The base plate 10 is provided with two upright positioned objects 11 for fastening of the delivery part 3, 4 to the base plate 10; the numbers of objects 11 are optional and the objects 11 can be either molded together with the base plate 10 or fastened to the base plate 10 after the base plate 10 has been formed e.g. by gluing or welding. The objects 11 are provided with sliding grooves 11a which sliding grooves 11a define the direction in which to move the delivery part 3, 4 when securing the delivery part 3, 4 to the base plate 10. In this embodiment each object 11 is provided with two sliding grooves 11a, and each sliding groove 11a is inclined in an angle B: 0°<B<90°. The sliding grooves 11a correspond to protruding parts 11b on the delivery part 3, 4. The interaction between the sliding grooves 11a of the base plate 10 and the protruding parts 11b of the delivery part 3 assures correct insertion of the connector needle 6 through the protective seal 7 of the injection part 1b as the delivery part 3 moves along a well defined path during fastening to the base plate 10.
Generally when the cannula part 1 is constructed of a two-part unit 1a, 1b the method for fastening the device to the skin of the patient will comprise the following step:
It is possible to vary the elasticity of the flexible portions 12 by varying the number of the portions 12 and the width and thickness of the portions 12.
The cannula part 1 comprises a body providing a through-going opening leading liquid to a not shown cannula 9 which cannula 9 extends at the proximal side of the injection part after insertion, i.e. the cannula part 1 partly forms the fluid connection between the patient and the reservoir 4. The cannula part 1 is also provided with a round-going upright wall 11 which in this embodiment constitutes the fastening means for the delivery device 3.
The delivery part and the injection part of this embodiment are joined by just pressing the two parts together.
In this embodiment the flexible portion 12 is constructed from the base plate 10 and formed like three spokes in a wheel.
The cannula part 1 is one unit comprising a molded body with an interior compartment. The interior compartment can e.g. be accessed through a protective seal by a connector needle when a delivery part including a house 3 and the reservoir 4 is placed in correct position.
The base plate 10 is like the embodiment of
a-b show different embodiments of the house 3 of the delivery part.
Number | Date | Country | Kind |
---|---|---|---|
2006 00103 | Jan 2006 | DK | national |
This application claims the benefit under 35 U.S.C. §371 of International Application No. PCT/DK2006/000737, filed Dec. 22, 2006, which claims the benefit of U.S. Provisional Application Ser. No. 60/753,684, filed Dec. 23, 2005, Danish Patent Application No. PA 2006 00103, filed Jan. 24, 2006, and U.S. Provisional Application Ser. No. 60/762,231, filed Jan. 25, 2006 and 60/816,767, filed Jun. 27, 2006. These references are incorporated herein in their entirety.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/DK2006/000737 | 12/22/2006 | WO | 00 | 11/26/2008 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2007/071255 | 6/28/2007 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
1592462 | MacGregor | Jun 1926 | A |
2047010 | Dickinson | Jun 1936 | A |
2295849 | Kayden | Sep 1942 | A |
2690529 | Lindblad | Sep 1954 | A |
2972779 | Cowley | Feb 1961 | A |
3059802 | Mitchell | Oct 1962 | A |
3074541 | Roehr | Jan 1963 | A |
3149186 | Coanda | Sep 1964 | A |
3221739 | Rosenthal | Dec 1965 | A |
3221740 | Rosenthal | Dec 1965 | A |
3306291 | Burke | Feb 1967 | A |
3485352 | Pilger | Dec 1969 | A |
3509879 | Bathish et al. | May 1970 | A |
3519158 | Anderson | Jul 1970 | A |
3547119 | Hall et al. | Dec 1970 | A |
3575337 | Bernhardt | Apr 1971 | A |
3610240 | Harautuneian | Oct 1971 | A |
3615039 | Ward | Oct 1971 | A |
3670727 | Reiterman | Jun 1972 | A |
3783895 | Weichselbaum | Jan 1974 | A |
3788374 | Saijo | Jan 1974 | A |
3810469 | Hurschman | May 1974 | A |
3835862 | Villari | Sep 1974 | A |
3840011 | Wright | Oct 1974 | A |
3893448 | Brantigan | Jul 1975 | A |
3937219 | Karakashian | Feb 1976 | A |
3986507 | Watt | Oct 1976 | A |
3986508 | Barrington | Oct 1976 | A |
3995518 | Spiroff | Dec 1976 | A |
4022205 | Tenczar | May 1977 | A |
4188950 | Wardlaw | Feb 1980 | A |
4201406 | Dennehey et al. | May 1980 | A |
4227528 | Wardlaw | Oct 1980 | A |
4259276 | Rawlings | Mar 1981 | A |
4267836 | Whitney et al. | May 1981 | A |
4296786 | Brignola | Oct 1981 | A |
4315505 | Crandall et al. | Feb 1982 | A |
4333455 | Bodicky | Jun 1982 | A |
4334551 | Pfister | Jun 1982 | A |
D267199 | Koenig | Dec 1982 | S |
4378015 | Wardlaw | Mar 1983 | A |
4402407 | Maly | Sep 1983 | A |
4415393 | Grimes | Nov 1983 | A |
4417886 | Frankhouser et al. | Nov 1983 | A |
4464178 | Dalton | Aug 1984 | A |
4473369 | Lueders et al. | Sep 1984 | A |
4484910 | Sarnoff et al. | Nov 1984 | A |
4500312 | McFarlane | Feb 1985 | A |
4508367 | Oreopoulos et al. | Apr 1985 | A |
4525157 | Vaillancourt | Jun 1985 | A |
4530695 | Phillips et al. | Jul 1985 | A |
4531937 | Yates | Jul 1985 | A |
4543088 | Bootman et al. | Sep 1985 | A |
4563177 | Kamen | Jan 1986 | A |
4610469 | Wolff-Mooij | Sep 1986 | A |
4617019 | Fecht | Oct 1986 | A |
4713059 | Bickelhaupt et al. | Dec 1987 | A |
4734092 | Millerd | Mar 1988 | A |
4755173 | Konopka et al. | Jul 1988 | A |
4817603 | Turner et al. | Apr 1989 | A |
RE32922 | Levin et al. | May 1989 | E |
4838871 | Luther | Jun 1989 | A |
4840613 | Balbierz | Jun 1989 | A |
4850974 | Bickelhaupt et al. | Jul 1989 | A |
4850996 | Cree | Jul 1989 | A |
4863016 | Fong et al. | Sep 1989 | A |
4878897 | Katzin | Nov 1989 | A |
4890608 | Steer | Jan 1990 | A |
4894054 | Miskinyar | Jan 1990 | A |
4895570 | Larkin | Jan 1990 | A |
4917669 | Bonaldo | Apr 1990 | A |
4935010 | Cox et al. | Jun 1990 | A |
4950163 | Zimble | Aug 1990 | A |
4950252 | Luther et al. | Aug 1990 | A |
4956989 | Nakajima | Sep 1990 | A |
4970954 | Weir et al. | Nov 1990 | A |
4978338 | Melsky et al. | Dec 1990 | A |
4982842 | Hollister | Jan 1991 | A |
4986817 | Code | Jan 1991 | A |
4994042 | Vadher | Feb 1991 | A |
4994045 | Ranford | Feb 1991 | A |
5011475 | Olsen | Apr 1991 | A |
5020665 | Bruno | Jun 1991 | A |
5024662 | Menes et al. | Jun 1991 | A |
5067496 | Eisele | Nov 1991 | A |
5092853 | Couvertier, II | Mar 1992 | A |
5098389 | Cappucci | Mar 1992 | A |
5112313 | Sallee | May 1992 | A |
5116319 | Van den Haak | May 1992 | A |
5116325 | Paterson | May 1992 | A |
5121751 | Panalletta | Jun 1992 | A |
5129884 | Dysarz | Jul 1992 | A |
5135502 | Koenig, Jr. et al. | Aug 1992 | A |
5137516 | Rand et al. | Aug 1992 | A |
5137524 | Lynn et al. | Aug 1992 | A |
5141496 | Dalto et al. | Aug 1992 | A |
5147375 | Sullivan et al. | Sep 1992 | A |
5163915 | Holleron | Nov 1992 | A |
5172808 | Bruno | Dec 1992 | A |
5176643 | Kramer et al. | Jan 1993 | A |
5176650 | Haining | Jan 1993 | A |
5176662 | Bartholomew et al. | Jan 1993 | A |
5186712 | Kelso et al. | Feb 1993 | A |
5188611 | Orgain | Feb 1993 | A |
RE34223 | Bonaldo | Apr 1993 | E |
5205820 | Kriesel | Apr 1993 | A |
5222947 | D'Amico | Jun 1993 | A |
5232454 | Hollister | Aug 1993 | A |
5248301 | Koenig et al. | Sep 1993 | A |
5256149 | Banik et al. | Oct 1993 | A |
5256152 | Marks | Oct 1993 | A |
5257980 | Van Antwerp et al. | Nov 1993 | A |
5267963 | Bachynsky | Dec 1993 | A |
5269799 | Daniel | Dec 1993 | A |
5271744 | Kramer et al. | Dec 1993 | A |
5279579 | D'Amico | Jan 1994 | A |
5279591 | Simon | Jan 1994 | A |
5282793 | Larson | Feb 1994 | A |
5300030 | Crossman et al. | Apr 1994 | A |
5312359 | Wallace | May 1994 | A |
5312369 | Arcusin et al. | May 1994 | A |
5316246 | Scott et al. | May 1994 | A |
5324302 | Crouse | Jun 1994 | A |
5342319 | Watson et al. | Aug 1994 | A |
5342324 | Tucker | Aug 1994 | A |
5344007 | Nakamura et al. | Sep 1994 | A |
5350392 | Purcell et al. | Sep 1994 | A |
5354280 | Haber et al. | Oct 1994 | A |
5354337 | Hoy | Oct 1994 | A |
5366469 | Steg et al. | Nov 1994 | A |
5372592 | Gambale | Dec 1994 | A |
5372787 | Ritter | Dec 1994 | A |
5376082 | Phelps | Dec 1994 | A |
5379895 | Foslien | Jan 1995 | A |
5384174 | Ward et al. | Jan 1995 | A |
5387197 | Smith et al. | Feb 1995 | A |
5390669 | Stuart et al. | Feb 1995 | A |
5391151 | Wilmot | Feb 1995 | A |
5403288 | Stanners | Apr 1995 | A |
5405332 | Opalek | Apr 1995 | A |
5425715 | Dalling et al. | Jun 1995 | A |
5429607 | McPhee | Jul 1995 | A |
5429613 | D'Amico | Jul 1995 | A |
5439473 | Jorgensen | Aug 1995 | A |
D362718 | Deily et al. | Sep 1995 | S |
5449349 | Sallee et al. | Sep 1995 | A |
5451210 | Kramer et al. | Sep 1995 | A |
5478316 | Bitdinger et al. | Dec 1995 | A |
5490841 | Landis | Feb 1996 | A |
5501675 | Erskine | Mar 1996 | A |
5505709 | Funderburk et al. | Apr 1996 | A |
5507730 | Haber et al. | Apr 1996 | A |
5514117 | Lynn | May 1996 | A |
5520654 | Wahlberg | May 1996 | A |
5522803 | Teisson-Simony | Jun 1996 | A |
5527287 | Miskinyar et al. | Jun 1996 | A |
5533974 | Gaba | Jul 1996 | A |
5540709 | Ramel | Jul 1996 | A |
5545143 | Fischell | Aug 1996 | A |
5545152 | Funderburk et al. | Aug 1996 | A |
5549577 | Siegel et al. | Aug 1996 | A |
5554130 | McDonald et al. | Sep 1996 | A |
5558650 | McPhee | Sep 1996 | A |
5562629 | Haughton et al. | Oct 1996 | A |
5562636 | Utterberg | Oct 1996 | A |
5573510 | Isaacson | Nov 1996 | A |
5575777 | Cover et al. | Nov 1996 | A |
5584813 | Livingston et al. | Dec 1996 | A |
5586553 | Halili | Dec 1996 | A |
5591188 | Waisman | Jan 1997 | A |
5599309 | Marshall et al. | Feb 1997 | A |
5599315 | McPhee | Feb 1997 | A |
5599318 | Sweeney et al. | Feb 1997 | A |
5628765 | Morita | May 1997 | A |
5643214 | Marshall | Jul 1997 | A |
5643216 | White | Jul 1997 | A |
5643220 | Cosme | Jul 1997 | A |
5658256 | Shields | Aug 1997 | A |
5662617 | Odell et al. | Sep 1997 | A |
5665071 | Wyrick | Sep 1997 | A |
5665075 | Gyure et al. | Sep 1997 | A |
5676156 | Yoon | Oct 1997 | A |
5681323 | Arick | Oct 1997 | A |
5695476 | Harris | Dec 1997 | A |
5697907 | Gaba | Dec 1997 | A |
5700250 | Erskine | Dec 1997 | A |
5702371 | Bierman | Dec 1997 | A |
5704920 | Gyure | Jan 1998 | A |
5709662 | Olive et al. | Jan 1998 | A |
5714225 | Hansen et al. | Feb 1998 | A |
5738641 | Watson et al. | Apr 1998 | A |
5741288 | Rife | Apr 1998 | A |
5752923 | Terwilliger | May 1998 | A |
5807316 | Teeple | Sep 1998 | A |
5807348 | Zinger et al. | Sep 1998 | A |
5810835 | Ryan et al. | Sep 1998 | A |
5817058 | Shaw | Oct 1998 | A |
5820598 | Gazza et al. | Oct 1998 | A |
5827236 | Takahashi | Oct 1998 | A |
5833666 | Davis et al. | Nov 1998 | A |
5843001 | Goldenberg | Dec 1998 | A |
5848990 | Cirelli et al. | Dec 1998 | A |
5851197 | Marano et al. | Dec 1998 | A |
5858001 | Tsals et al. | Jan 1999 | A |
5865806 | Howell | Feb 1999 | A |
5899886 | Cosme | May 1999 | A |
5911705 | Howell | Jun 1999 | A |
5913846 | Szabo | Jun 1999 | A |
5916199 | Miles | Jun 1999 | A |
5919167 | Mulhauser et al. | Jul 1999 | A |
5919170 | Woessner | Jul 1999 | A |
5925032 | Clements | Jul 1999 | A |
5935109 | Donnan | Aug 1999 | A |
5947931 | Bierman | Sep 1999 | A |
5947935 | Rinehart et al. | Sep 1999 | A |
5951523 | Osterlind et al. | Sep 1999 | A |
5954643 | VanAntwerp et al. | Sep 1999 | A |
5957892 | Thorne | Sep 1999 | A |
5957897 | Jeffrey | Sep 1999 | A |
5968011 | Larsen et al. | Oct 1999 | A |
5971966 | Lav | Oct 1999 | A |
5975120 | Novosel | Nov 1999 | A |
5980488 | Thorne | Nov 1999 | A |
5980506 | Mathiasen | Nov 1999 | A |
5984224 | Yang | Nov 1999 | A |
5984897 | Peterson et al. | Nov 1999 | A |
D417733 | Howell et al. | Dec 1999 | S |
6017328 | Fischell et al. | Jan 2000 | A |
6017598 | Kreischer et al. | Jan 2000 | A |
D421119 | Musgrave et al. | Feb 2000 | S |
6024727 | Thorne et al. | Feb 2000 | A |
6039629 | Mitchell | Mar 2000 | A |
6042570 | Bell et al. | Mar 2000 | A |
6045533 | Kriesel et al. | Apr 2000 | A |
6045534 | Jacobsen et al. | Apr 2000 | A |
6050976 | Thorne et al. | Apr 2000 | A |
6053893 | Bucher | Apr 2000 | A |
6053930 | Ruppert | Apr 2000 | A |
6056718 | Funderburk et al. | May 2000 | A |
6056726 | Isaacson | May 2000 | A |
6074369 | Sage et al. | Jun 2000 | A |
6074371 | Fischell | Jun 2000 | A |
6077244 | Botich et al. | Jun 2000 | A |
6079432 | Paradis | Jun 2000 | A |
6086008 | Gray et al. | Jul 2000 | A |
6086575 | Mejslov | Jul 2000 | A |
6090068 | Chanut | Jul 2000 | A |
6093172 | Funderburk et al. | Jul 2000 | A |
6093179 | O'Hara et al. | Jul 2000 | A |
6099503 | Stardella | Aug 2000 | A |
6105218 | Reekie | Aug 2000 | A |
6106498 | Friedli et al. | Aug 2000 | A |
6120482 | Szabo | Sep 2000 | A |
6123690 | Mejslov | Sep 2000 | A |
6132755 | Eicher et al. | Oct 2000 | A |
6139534 | Niedospial, Jr. | Oct 2000 | A |
6159181 | Crossman et al. | Dec 2000 | A |
6183464 | Sharp et al. | Feb 2001 | B1 |
6191338 | Haller | Feb 2001 | B1 |
6193694 | Bell et al. | Feb 2001 | B1 |
6210420 | Mauze et al. | Apr 2001 | B1 |
6219574 | Cormier et al. | Apr 2001 | B1 |
6221058 | Kao et al. | Apr 2001 | B1 |
6248093 | Moberg | Jun 2001 | B1 |
6293925 | Safabash et al. | Sep 2001 | B1 |
6302866 | Marggi | Oct 2001 | B1 |
6319232 | Kashmer | Nov 2001 | B1 |
6322535 | Hitchins et al. | Nov 2001 | B1 |
6322808 | Trautman et al. | Nov 2001 | B1 |
6334856 | Allen et al. | Jan 2002 | B1 |
6355021 | Nielsen et al. | Mar 2002 | B1 |
6364113 | Faasse et al. | Apr 2002 | B1 |
6378218 | Sigwart et al. | Apr 2002 | B2 |
6379335 | Rigon et al. | Apr 2002 | B1 |
6387076 | Van Lunduyt | May 2002 | B1 |
6387078 | Gillespie, III | May 2002 | B1 |
6405876 | Seshimoto et al. | Jun 2002 | B1 |
6440096 | Lastovich et al. | Aug 2002 | B1 |
6447482 | Rønborg et al. | Sep 2002 | B1 |
6450992 | Cassidy, Jr. | Sep 2002 | B1 |
6485461 | Mason et al. | Nov 2002 | B1 |
6488663 | Steg | Dec 2002 | B1 |
6503222 | Lo | Jan 2003 | B2 |
6517517 | Farrugia et al. | Feb 2003 | B1 |
6520938 | Funderburk et al. | Feb 2003 | B1 |
D472316 | Douglas et al. | Mar 2003 | S |
D472630 | Douglas et al. | Apr 2003 | S |
6572586 | Wojcik | Jun 2003 | B1 |
6579267 | Lynch et al. | Jun 2003 | B2 |
6582397 | Alesi et al. | Jun 2003 | B2 |
6595962 | Perthu | Jul 2003 | B1 |
6607509 | Bobroff et al. | Aug 2003 | B2 |
6607511 | Halseth et al. | Aug 2003 | B2 |
6613064 | Rutynowski et al. | Sep 2003 | B2 |
6620133 | Steck | Sep 2003 | B1 |
6620136 | Pressly, Sr. et al. | Sep 2003 | B1 |
6620140 | Metzger | Sep 2003 | B1 |
6629949 | Douglas | Oct 2003 | B1 |
6645181 | Lavi et al. | Nov 2003 | B1 |
6645182 | Szabo | Nov 2003 | B1 |
6659982 | Douglas et al. | Dec 2003 | B2 |
6685674 | Douglas et al. | Feb 2004 | B2 |
6699218 | Flaherty et al. | Mar 2004 | B2 |
6702779 | Connelly et al. | Mar 2004 | B2 |
6726649 | Swenson et al. | Apr 2004 | B2 |
6736797 | Larsen et al. | May 2004 | B1 |
6743203 | Pickhard | Jun 2004 | B1 |
6749587 | Flaherty | Jun 2004 | B2 |
6749589 | Douglas et al. | Jun 2004 | B1 |
6755805 | Reid | Jun 2004 | B1 |
6776775 | Mohammad | Aug 2004 | B1 |
6790199 | Gianakos | Sep 2004 | B1 |
6805686 | Fathallah et al. | Oct 2004 | B1 |
6808506 | Lastovich et al. | Oct 2004 | B2 |
6811545 | Vaillancourt | Nov 2004 | B2 |
6814720 | Olsen et al. | Nov 2004 | B2 |
6824530 | Wagner et al. | Nov 2004 | B2 |
6824531 | Zecha, Jr. et al. | Nov 2004 | B1 |
6830562 | Mogensen et al. | Dec 2004 | B2 |
6837877 | Zurcher | Jan 2005 | B2 |
6837878 | Smutney et al. | Jan 2005 | B2 |
6840922 | Nielsen et al. | Jan 2005 | B2 |
6880701 | Bergeron et al. | Apr 2005 | B2 |
6923791 | Douglas | Aug 2005 | B2 |
6926694 | Marano-Ford et al. | Aug 2005 | B2 |
6939324 | Gonnelli et al. | Sep 2005 | B2 |
6939331 | Ohshima | Sep 2005 | B2 |
6949084 | Marggi et al. | Sep 2005 | B2 |
6959812 | Reif et al. | Nov 2005 | B2 |
6960193 | Rosenberg | Nov 2005 | B2 |
6979316 | Rubin et al. | Dec 2005 | B1 |
6991619 | Marano-Ford et al. | Jan 2006 | B2 |
6991620 | Marano-Ford et al. | Jan 2006 | B2 |
6994213 | Giard et al. | Feb 2006 | B2 |
6997907 | Safabash et al. | Feb 2006 | B2 |
7014625 | Bengtsson | Mar 2006 | B2 |
7018344 | Bressler et al. | Mar 2006 | B2 |
7022108 | Marano-Ford et al. | Apr 2006 | B2 |
7047070 | Wilkenson et al. | May 2006 | B2 |
7052483 | Wojcik | May 2006 | B2 |
7055713 | Rea et al. | Jun 2006 | B2 |
7056302 | Douglas | Jun 2006 | B2 |
7070580 | Nielsen | Jul 2006 | B2 |
7074208 | Pajunk et al. | Jul 2006 | B2 |
D526409 | Nielsen et al. | Aug 2006 | S |
7083592 | Lastovich et al. | Aug 2006 | B2 |
7083597 | Lynch et al. | Aug 2006 | B2 |
7097631 | Trautman et al. | Aug 2006 | B2 |
7109878 | Mann et al. | Sep 2006 | B2 |
7115108 | Wilkenson et al. | Oct 2006 | B2 |
7115112 | Mogensen et al. | Oct 2006 | B2 |
7141023 | Diermann et al. | Nov 2006 | B2 |
7147623 | Mathiasen | Dec 2006 | B2 |
7186236 | Gibson et al. | Mar 2007 | B2 |
7211068 | Douglas | May 2007 | B2 |
7214207 | Lynch et al. | May 2007 | B2 |
7214215 | Heinzerling et al. | May 2007 | B2 |
7250037 | Shermer et al. | Jul 2007 | B2 |
7258680 | Mogensen et al. | Aug 2007 | B2 |
D554253 | Kornerup | Oct 2007 | S |
7303543 | Maule et al. | Dec 2007 | B1 |
7309326 | Fangrow, Jr. | Dec 2007 | B2 |
7322473 | Fux | Jan 2008 | B2 |
7407491 | Fangrow, Jr. | Aug 2008 | B2 |
7407493 | Cane′ | Aug 2008 | B2 |
7431876 | Mejlhede et al. | Oct 2008 | B2 |
7441655 | Hoftman | Oct 2008 | B1 |
7569262 | Szabo et al. | Aug 2009 | B2 |
7648494 | Kornerup et al. | Jan 2010 | B2 |
7766867 | Lynch et al. | Aug 2010 | B2 |
7846132 | Gravesen et al. | Dec 2010 | B2 |
7850652 | Liniger et al. | Dec 2010 | B2 |
8012126 | Tipsmark et al. | Sep 2011 | B2 |
8087333 | Oishi | Jan 2012 | B2 |
8123724 | Gillespie, III | Feb 2012 | B2 |
8303549 | Mejlhede et al. | Nov 2012 | B2 |
20010004970 | Hollister et al. | Jun 2001 | A1 |
20010016714 | Bell et al. | Aug 2001 | A1 |
20010021827 | Ferguson et al. | Sep 2001 | A1 |
20010039387 | Rutynowski et al. | Nov 2001 | A1 |
20010039401 | Ferguson et al. | Nov 2001 | A1 |
20010041875 | Higuchi et al. | Nov 2001 | A1 |
20010049496 | Kirchhofer | Dec 2001 | A1 |
20010053889 | Marggi | Dec 2001 | A1 |
20010056284 | Purcell et al. | Dec 2001 | A1 |
20020022798 | Connelly | Feb 2002 | A1 |
20020022855 | Bobroff et al. | Feb 2002 | A1 |
20020026152 | Bierman | Feb 2002 | A1 |
20020055711 | Lavi et al. | May 2002 | A1 |
20020068904 | Pluth et al. | Jun 2002 | A1 |
20020072720 | Hague et al. | Jun 2002 | A1 |
20020074345 | Scheider et al. | Jun 2002 | A1 |
20020077599 | Wojcik | Jun 2002 | A1 |
20020082543 | Park et al. | Jun 2002 | A1 |
20020107489 | Lee | Aug 2002 | A1 |
20020111581 | Sasso | Aug 2002 | A1 |
20020156424 | Suzuki et al. | Oct 2002 | A1 |
20020156427 | Suzuki et al. | Oct 2002 | A1 |
20020161322 | Utterberg et al. | Oct 2002 | A1 |
20020161332 | Ramey | Oct 2002 | A1 |
20020161386 | Halseth et al. | Oct 2002 | A1 |
20020165493 | Bierman | Nov 2002 | A1 |
20020169419 | Steg | Nov 2002 | A1 |
20020173748 | McConnell et al. | Nov 2002 | A1 |
20020173769 | Gray et al. | Nov 2002 | A1 |
20020183688 | Lastovich et al. | Dec 2002 | A1 |
20020189688 | Roorda | Dec 2002 | A1 |
20020193737 | Popovsky | Dec 2002 | A1 |
20020193744 | Alesi et al. | Dec 2002 | A1 |
20030014018 | Giambattista et al. | Jan 2003 | A1 |
20030060781 | Mogensen et al. | Mar 2003 | A1 |
20030069548 | Connelly et al. | Apr 2003 | A1 |
20030088238 | Poulsen et al. | May 2003 | A1 |
20030105430 | Lavi et al. | Jun 2003 | A1 |
20030109829 | Mogensen et al. | Jun 2003 | A1 |
20030125669 | Safabash et al. | Jul 2003 | A1 |
20030125678 | Swenson et al. | Jul 2003 | A1 |
20030130619 | Safabash et al. | Jul 2003 | A1 |
20030139704 | Lin | Jul 2003 | A1 |
20030158520 | Safabash et al. | Aug 2003 | A1 |
20030176843 | Wilkinson | Sep 2003 | A1 |
20030176852 | Lynch et al. | Sep 2003 | A1 |
20030181863 | Davis et al. | Sep 2003 | A1 |
20030181868 | Swenson | Sep 2003 | A1 |
20030181873 | Swenson | Sep 2003 | A1 |
20030181874 | Bressler et al. | Sep 2003 | A1 |
20030187394 | Wilkinson et al. | Oct 2003 | A1 |
20030187395 | Gabel | Oct 2003 | A1 |
20030199823 | Bobroff et al. | Oct 2003 | A1 |
20030216686 | Lynch et al. | Nov 2003 | A1 |
20030220610 | Lastovich et al. | Nov 2003 | A1 |
20030225373 | Bobroff et al. | Dec 2003 | A1 |
20030225374 | Mathiasen | Dec 2003 | A1 |
20030229308 | Tsals et al. | Dec 2003 | A1 |
20030229316 | Hwang et al. | Dec 2003 | A1 |
20040002682 | Kovelman et al. | Jan 2004 | A1 |
20040006316 | Patton | Jan 2004 | A1 |
20040044306 | Lynch et al. | Mar 2004 | A1 |
20040049159 | Barrus et al. | Mar 2004 | A1 |
20040059316 | Smedegaard | Mar 2004 | A1 |
20040068231 | Blondeau | Apr 2004 | A1 |
20040069044 | Lavi et al. | Apr 2004 | A1 |
20040087913 | Rogers et al. | May 2004 | A1 |
20040092865 | Flaherty et al. | May 2004 | A1 |
20040092875 | Kochamba | May 2004 | A1 |
20040111068 | Swenson | Jun 2004 | A1 |
20040112781 | Hofverberg et al. | Jun 2004 | A1 |
20040116865 | Bengtsson | Jun 2004 | A1 |
20040133164 | Funderburk et al. | Jul 2004 | A1 |
20040138612 | Shermer et al. | Jul 2004 | A1 |
20040138620 | Douglas et al. | Jul 2004 | A1 |
20040143216 | Douglas et al. | Jul 2004 | A1 |
20040143218 | Das | Jul 2004 | A1 |
20040158202 | Jensen | Aug 2004 | A1 |
20040158207 | Hunn et al. | Aug 2004 | A1 |
20040162518 | Connelly et al. | Aug 2004 | A1 |
20040162521 | Bengtsson | Aug 2004 | A1 |
20040171989 | Horner et al. | Sep 2004 | A1 |
20040178098 | Swenson et al. | Sep 2004 | A1 |
20040186446 | Ohshima | Sep 2004 | A1 |
20040193143 | Sauer | Sep 2004 | A1 |
20040199123 | Nielsen | Oct 2004 | A1 |
20040204673 | Flaherty et al. | Oct 2004 | A1 |
20040204687 | Mogensen et al. | Oct 2004 | A1 |
20040204690 | Yashiro et al. | Oct 2004 | A1 |
20040215151 | Marshall et al. | Oct 2004 | A1 |
20040220528 | Garcia, Jr. | Nov 2004 | A1 |
20040236284 | Hoste et al. | Nov 2004 | A1 |
20040238392 | Peterson et al. | Dec 2004 | A1 |
20040243065 | McConnell et al. | Dec 2004 | A1 |
20040254433 | Bandis et al. | Dec 2004 | A1 |
20040260235 | Douglas | Dec 2004 | A1 |
20040260250 | Harris et al. | Dec 2004 | A1 |
20050035014 | Cane | Feb 2005 | A1 |
20050038378 | Lastovich et al. | Feb 2005 | A1 |
20050043687 | Mogensen et al. | Feb 2005 | A1 |
20050049571 | Lastovich et al. | Mar 2005 | A1 |
20050065466 | Vedrine | Mar 2005 | A1 |
20050065472 | Cindrich et al. | Mar 2005 | A1 |
20050075606 | Botich et al. | Apr 2005 | A1 |
20050080386 | Reid | Apr 2005 | A1 |
20050101910 | Bowman et al. | May 2005 | A1 |
20050101912 | Faust et al. | May 2005 | A1 |
20050101932 | Cote et al. | May 2005 | A1 |
20050101933 | Marrs et al. | May 2005 | A1 |
20050107743 | Fangrow, Jr. | May 2005 | A1 |
20050113761 | Faust et al. | May 2005 | A1 |
20050119611 | Marano-Ford et al. | Jun 2005 | A1 |
20050119619 | Haining | Jun 2005 | A1 |
20050119637 | Lundgren et al. | Jun 2005 | A1 |
20050124936 | Mogensen et al. | Jun 2005 | A1 |
20050131347 | Marano-Ford et al. | Jun 2005 | A1 |
20050159709 | Wilkinson | Jul 2005 | A1 |
20050159714 | Gibson | Jul 2005 | A1 |
20050165382 | Fulford | Jul 2005 | A1 |
20050192560 | Walls et al. | Sep 2005 | A1 |
20050203461 | Flaherty et al. | Sep 2005 | A1 |
20050215979 | Kornerup et al. | Sep 2005 | A1 |
20050240154 | Mogensen et al. | Oct 2005 | A1 |
20050251098 | Wyss et al. | Nov 2005 | A1 |
20050256456 | Marano-Ford et al. | Nov 2005 | A1 |
20050261629 | Marano-Ford et al. | Nov 2005 | A1 |
20050277892 | Chen | Dec 2005 | A1 |
20050283114 | Bresina et al. | Dec 2005 | A1 |
20060015063 | Butikofer et al. | Jan 2006 | A1 |
20060015076 | Heinzerling et al. | Jan 2006 | A1 |
20060030815 | Csincsura et al. | Feb 2006 | A1 |
20060036214 | Mogensen et al. | Feb 2006 | A1 |
20060041224 | Jensen | Feb 2006 | A1 |
20060069351 | Safabash et al. | Mar 2006 | A9 |
20060069382 | Pedersen | Mar 2006 | A1 |
20060069383 | Bogaerts et al. | Mar 2006 | A1 |
20060095003 | Marano-Ford et al. | May 2006 | A1 |
20060095014 | Ethelfeld | May 2006 | A1 |
20060106346 | Sullivan et al. | May 2006 | A1 |
20060129123 | Wojcik | Jun 2006 | A1 |
20060135908 | Liniger et al. | Jun 2006 | A1 |
20060135913 | Ethelfeld | Jun 2006 | A1 |
20060142698 | Ethelfeld | Jun 2006 | A1 |
20060161108 | Mogensen et al. | Jul 2006 | A1 |
20060173410 | Moberg et al. | Aug 2006 | A1 |
20060173413 | Fan | Aug 2006 | A1 |
20060184104 | Cheney, II et al. | Aug 2006 | A1 |
20060184140 | Okiyama | Aug 2006 | A1 |
20060200073 | Radmer et al. | Sep 2006 | A1 |
20060241551 | Lynch et al. | Oct 2006 | A1 |
20060247553 | Diermann et al. | Nov 2006 | A1 |
20060247574 | Maule et al. | Nov 2006 | A1 |
20060253085 | Geismar et al. | Nov 2006 | A1 |
20060253086 | Moberg et al. | Nov 2006 | A1 |
20060264835 | Nielsen et al. | Nov 2006 | A1 |
20060264890 | Moberg et al. | Nov 2006 | A1 |
20070005017 | Alchas et al. | Jan 2007 | A1 |
20070016129 | Liniger et al. | Jan 2007 | A1 |
20070016159 | Sparholt et al. | Jan 2007 | A1 |
20070021729 | Mogensen et al. | Jan 2007 | A1 |
20070049865 | Radmer et al. | Mar 2007 | A1 |
20070049870 | Gray et al. | Mar 2007 | A1 |
20070051784 | Money et al. | Mar 2007 | A1 |
20070066955 | Sparholt et al. | Mar 2007 | A1 |
20070088271 | Richards et al. | Apr 2007 | A1 |
20070093754 | Mogensen | Apr 2007 | A1 |
20070104596 | Preuthun et al. | May 2007 | A1 |
20070112301 | Preuthun et al. | May 2007 | A1 |
20070112303 | Liniger | May 2007 | A1 |
20070129688 | Scheider et al. | Jun 2007 | A1 |
20070173767 | Lynch et al. | Jul 2007 | A1 |
20070179444 | Causey et al. | Aug 2007 | A1 |
20070185441 | Fangrow, Jr. | Aug 2007 | A1 |
20070191772 | Wojcik | Aug 2007 | A1 |
20070191773 | Wojcik | Aug 2007 | A1 |
20070203454 | Shermer et al. | Aug 2007 | A1 |
20070213673 | Douglas | Sep 2007 | A1 |
20070244448 | Lastovich et al. | Oct 2007 | A1 |
20070299409 | Whitbourne et al. | Dec 2007 | A1 |
20080269687 | Chong | Oct 2008 | A1 |
20080312601 | Cane′ | Dec 2008 | A1 |
20090062767 | Van Antwerp et al. | Mar 2009 | A1 |
20090326456 | Cross et al. | Dec 2009 | A1 |
20100004597 | Gyrn et al. | Jan 2010 | A1 |
20100137829 | Nielsen et al. | Jun 2010 | A1 |
20100228226 | Nielsen | Sep 2010 | A1 |
20100262078 | Blomquist | Oct 2010 | A1 |
Number | Date | Country |
---|---|---|
4 342 329 | Jun 1994 | DE |
196 31 921 | Mar 1997 | DE |
299 05 072 | Sep 1999 | DE |
101 17 285 | Nov 2002 | DE |
203 20 207 | Nov 2004 | DE |
0117632 | Sep 1984 | EP |
0239244 | Feb 1987 | EP |
0272530 | Jun 1988 | EP |
0451040 | Oct 1991 | EP |
0544837 | Jun 1993 | EP |
0615768 | Sep 1994 | EP |
0651662 | May 1995 | EP |
0652027 | May 1995 | EP |
0657184 | Jun 1995 | EP |
0688232 | Dec 1995 | EP |
0714631 | Jun 1996 | EP |
0744183 | Nov 1996 | EP |
0747006 | Dec 1996 | EP |
0799626 | Oct 1997 | EP |
0 937 475 | Aug 1999 | EP |
0956879 | Nov 1999 | EP |
1086718 | Mar 2001 | EP |
1125593 | Aug 2001 | EP |
0775501 | Jun 2002 | EP |
1329233 | Jul 2003 | EP |
1350537 | Oct 2003 | EP |
1360970 | Nov 2003 | EP |
1380315 | Jan 2004 | EP |
1407747 | Apr 2004 | EP |
1407793 | Apr 2004 | EP |
1421968 | May 2004 | EP |
1177802 | Sep 2004 | EP |
1475113 | Nov 2004 | EP |
1 495 775 | Jan 2005 | EP |
1502613 | Feb 2005 | EP |
1525873 | Apr 2005 | EP |
1 527 792 | May 2005 | EP |
1527792 | May 2005 | EP |
1559442 | Aug 2005 | EP |
1616594 | Jan 2006 | EP |
1704889 | Sep 2006 | EP |
1719537 | Nov 2006 | EP |
1762259 | Mar 2007 | EP |
1764125 | Mar 2007 | EP |
1776980 | Apr 2007 | EP |
1970091 | Sep 2008 | EP |
2272559 | Jan 2011 | EP |
2725902 | Oct 1994 | FR |
906574 | Sep 1962 | GB |
2 088 215 | Jun 1982 | GB |
2 230 702 | Oct 1990 | GB |
2 423 267 | Aug 2006 | GB |
2 450 872 | Jul 2007 | GB |
10179734 | Aug 1991 | JP |
7051251 | Nov 1995 | JP |
8187286 | Jul 1996 | JP |
03-191965 | Jul 1998 | JP |
2002-028246 | Jan 2002 | JP |
2 238 111 | Dec 2003 | RU |
933 100 | Jun 1982 | SU |
WO 8101795 | Jul 1981 | WO |
WO 8203558 | Oct 1982 | WO |
WO 9204062 | Mar 1992 | WO |
WO 9305840 | Apr 1993 | WO |
WO 9311709 | Jun 1993 | WO |
WO 9420160 | Sep 1994 | WO |
WO 9519194 | Jul 1995 | WO |
WO 9632981 | Jul 1996 | WO |
WO 9620021 | Oct 1996 | WO |
WO 9826835 | Jun 1998 | WO |
WO 9833549 | Aug 1998 | WO |
WO 9858693 | Dec 1998 | WO |
WO 9907435 | Feb 1999 | WO |
WO9922789 | May 1999 | WO |
WO 9933504 | Jul 1999 | WO |
WO 0002614 | Jan 2000 | WO |
WO 0003757 | Jan 2000 | WO |
WO 0044324 | Aug 2000 | WO |
WO 0112746 | Feb 2001 | WO |
WO 0130419 | May 2001 | WO |
WO 0168180 | Sep 2001 | WO |
WO 0172353 | Oct 2001 | WO |
WO 0176684 | Oct 2001 | WO |
WO 0193926 | Dec 2001 | WO |
WO 0202165 | Jan 2002 | WO |
WO 0207804 | Jan 2002 | WO |
WO 0240083 | May 2002 | WO |
WO 0240083 | May 2002 | WO |
WO 02053220 | Jul 2002 | WO |
WO 02081012 | Oct 2002 | WO |
WO 02081013 | Oct 2002 | WO |
WO 02083206 | Oct 2002 | WO |
WO 02094352 | Nov 2002 | WO |
WO 02100457 | Dec 2002 | WO |
WO 02102442 | Dec 2002 | WO |
WO 02068014 | Jan 2003 | WO |
WO 03015860 | Feb 2003 | WO |
WO 03026728 | Apr 2003 | WO |
WO 03068305 | Aug 2003 | WO |
WO 03075980 | Sep 2003 | WO |
WO 03095003 | Nov 2003 | WO |
WO 2004012796 | Feb 2004 | WO |
WO 2004026375 | Apr 2004 | WO |
WO 2004029457 | Apr 2004 | WO |
WO 2004030726 | Apr 2004 | WO |
WO 2004037325 | May 2004 | WO |
WO 2004054644 | Jul 2004 | WO |
WO 2004056412 | Jul 2004 | WO |
WO 2004064593 | Aug 2004 | WO |
WO 2004071308 | Aug 2004 | WO |
WO 2004087240 | Oct 2004 | WO |
WO 2004098683 | Nov 2004 | WO |
WO 2004101016 | Nov 2004 | WO |
WO 2004101071 | Nov 2004 | WO |
WO 2004110527 | Dec 2004 | WO |
WO 2005002649 | Jan 2005 | WO |
WO 2005004973 | Jan 2005 | WO |
WO 2005018703 | Mar 2005 | WO |
WO 2005037184 | Apr 2005 | WO |
WO 2005037350 | Apr 2005 | WO |
WO 2005039673 | May 2005 | WO |
WO 2005046780 | May 2005 | WO |
WO 2005065748 | Jul 2005 | WO |
WO 2005068006 | Jul 2005 | WO |
WO 2005072795 | Aug 2005 | WO |
WO 2005092410 | Oct 2005 | WO |
WO 2005094920 | Oct 2005 | WO |
WO 2005118055 | Dec 2005 | WO |
WO 2006003130 | Jan 2006 | WO |
WO 2006015507 | Feb 2006 | WO |
WO 2006015600 | Feb 2006 | WO |
WO 2006024650 | Mar 2006 | WO |
WO 2006032689 | Mar 2006 | WO |
WO 2006032692 | Mar 2006 | WO |
WO 2006061027 | Jun 2006 | WO |
WO 2006061354 | Jun 2006 | WO |
WO 2006062680 | Jun 2006 | WO |
WO 2006062912 | Jun 2006 | WO |
WO 2006075016 | Jul 2006 | WO |
WO 2006077262 | Jul 2006 | WO |
WO 2006077263 | Jul 2006 | WO |
WO 2006089958 | Aug 2006 | WO |
WO 2006097111 | Sep 2006 | WO |
WO 2006108775 | Oct 2006 | WO |
WO 2006120253 | Nov 2006 | WO |
WO 2006121921 | Nov 2006 | WO |
WO 2006122048 | Nov 2006 | WO |
WO 2007000162 | Jan 2007 | WO |
WO 2007002523 | Jan 2007 | WO |
WO 2007020090 | Feb 2007 | WO |
WO 2007065944 | Jun 2007 | WO |
WO 2007071255 | Jun 2007 | WO |
WO 2007071258 | Jun 2007 | WO |
WO 2007093051 | Aug 2007 | WO |
WO 2007093182 | Aug 2007 | WO |
WO 2007122207 | Nov 2007 | WO |
WO 2007140631 | Dec 2007 | WO |
WO 2007140783 | Dec 2007 | WO |
WO 2007140785 | Dec 2007 | WO |
WO 2007141210 | Dec 2007 | WO |
WO 2008014791 | Feb 2008 | WO |
WO 2008014792 | Feb 2008 | WO |
WO 2008048631 | Apr 2008 | WO |
WO 2008052545 | May 2008 | WO |
WO 2008065646 | Jun 2008 | WO |
WO 2008092782 | Aug 2008 | WO |
WO 2008092958 | Aug 2008 | WO |
WO 2008092959 | Aug 2008 | WO |
WO 2008135098 | Nov 2008 | WO |
WO 2008148714 | Dec 2008 | WO |
WO 2008155145 | Dec 2008 | WO |
WO 2008155377 | Dec 2008 | WO |
WO 2009004026 | Jan 2009 | WO |
WO 2009007287 | Jan 2009 | WO |
WO 2009010396 | Jan 2009 | WO |
WO 2009010399 | Jan 2009 | WO |
WO 2009016635 | Feb 2009 | WO |
WO 2009098291 | Aug 2009 | WO |
WO 2009098306 | Aug 2009 | WO |
WO 2009101130 | Aug 2009 | WO |
WO 2009101145 | Aug 2009 | WO |
WO 2009103759 | Aug 2009 | WO |
WO 2009106517 | Sep 2009 | WO |
WO 2009144272 | Dec 2009 | WO |
WO 2010003885 | Jan 2010 | WO |
WO 2010003886 | Jan 2010 | WO |
WO 2010030602 | Mar 2010 | WO |
WO 2010034830 | Apr 2010 | WO |
WO 2010072664 | Jul 2010 | WO |
WO 2010112521 | Oct 2010 | WO |
WO 2011012465 | Feb 2011 | WO |
WO 2011015659 | Feb 2011 | WO |
WO 2011121023 | Oct 2011 | WO |
Entry |
---|
“Why inset®?” inset® infusion set product overview; http://web.archive.org/web/20040906102448/http://www.infusion- set.com/Default.asp?ID=108; two pages. |
International-Type Search Report for Danish Application No. DK 2006/00103 completed Sep. 20, 2006. |
International Search Report for International Application No. PCT/DK2006/000737 completed Feb. 14, 2007. |
Number | Date | Country | |
---|---|---|---|
20090076453 A1 | Mar 2009 | US |
Number | Date | Country | |
---|---|---|---|
60753684 | Dec 2005 | US | |
60762231 | Jan 2006 | US | |
60816767 | Jun 2006 | US |